Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Giovannoni

Showing results (1-10 of 685) with videos related to

Pageof 69
Sort By:
The Lancet. Neurology|December 8, 2011
The REFLEX study: a missed opportunity?Gavin Giovannoni
Neurology|July 21, 2010
CSF GFAP: Volcanic ash from anti-aquaporin-4 antibody-mediated destruction of astrocytesGavin Giovannoni
Multiple Sclerosis and Related Disorders|July 27, 2016
Why do you have to be lucky to get the MS treatment you deserve?Gavin Giovannoni
The Lancet. Neurology|August 4, 2019
Do we have equipoise when it comes to how we treat active multiple sclerosis?Gavin Giovannoni
Multiple Sclerosis and Related Disorders|April 17, 2015
ECTRIMS 2012: Treatment highlightsGavin Giovannoni
Multiple Sclerosis and Related Disorders|December 31, 2018
Is the 'MS establishment' biased; the case for addressing gender inequality in the field of MS?Gavin Giovannoni
Brain : a Journal of Neurology|July 31, 2018
Peripheral blood neurofilament light chain levels: the neurologist's C-reactive protein?Gavin Giovannoni
Multiple Sclerosis and Related Disorders|September 20, 2016
Time and brain health both matter in multiple sclerosisGavin Giovannoni
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2010
Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the 'Spinal Tap'Gavin Giovannoni
The Lancet. Neurology|May 16, 2017
The neurodegenerative prodrome in multiple sclerosisGavin Giovannoni
Pageof 69

Showing results (1-10 of 685) with videos related to

Sort By:
Pageof 69
The Lancet. Neurology|December 8, 2011
The REFLEX study: a missed opportunity?Gavin Giovannoni
Neurology|July 21, 2010
CSF GFAP: Volcanic ash from anti-aquaporin-4 antibody-mediated destruction of astrocytesGavin Giovannoni
Multiple Sclerosis and Related Disorders|July 27, 2016
Why do you have to be lucky to get the MS treatment you deserve?Gavin Giovannoni
The Lancet. Neurology|August 4, 2019
Do we have equipoise when it comes to how we treat active multiple sclerosis?Gavin Giovannoni
Multiple Sclerosis and Related Disorders|April 17, 2015
ECTRIMS 2012: Treatment highlightsGavin Giovannoni
Multiple Sclerosis and Related Disorders|December 31, 2018
Is the 'MS establishment' biased; the case for addressing gender inequality in the field of MS?Gavin Giovannoni
Brain : a Journal of Neurology|July 31, 2018
Peripheral blood neurofilament light chain levels: the neurologist's C-reactive protein?Gavin Giovannoni
Multiple Sclerosis and Related Disorders|September 20, 2016
Time and brain health both matter in multiple sclerosisGavin Giovannoni
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2010
Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the 'Spinal Tap'Gavin Giovannoni
The Lancet. Neurology|May 16, 2017
The neurodegenerative prodrome in multiple sclerosisGavin Giovannoni
Pageof 69